Human Genome Epidemiology Literature Finder
Records 1 - 8 (of 8 Records) |
Query Trace: Breast Neoplasms and meta-analysis and CYP2D6[original query] |
---|
Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis. Breast cancer research and treatment 2010 Aug 122 (3): 609-17. Seruga Bostjan, Amir Eit |
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations. Clinical pharmacology and therapeutics 2014 Feb 95 (2): 216-27. Province M A, Goetz M P, Brauch H, Flockhart D A, Hebert J M, Whaley R, Suman V J, Schroth W, Winter S, Zembutsu H, Mushiroda T, Newman W G, Lee M-T M, Ambrosone C B, Beckmann M W, Choi J-Y, Dieudonné A-S, Fasching P A, Ferraldeschi R, Gong L, Haschke-Becher E, Howell A, Jordan L B, Hamann U, Kiyotani K, Krippl P, Lambrechts D, Latif A, Langsenlehner U, Lorizio W, Neven P, Nguyen A T, Park B-W, Purdie C A, Quinlan P, Renner W, Schmidt M, Schwab M, Shin J-G, Stingl J C, Wegman P, Wingren S, Wu A H B, Ziv E, Zirpoli G, Thompson A M, Jordan V C, Nakamura Y, Altman R B, Ames M M, Weinshilboum R M, Eichelbaum M, Ingle J N, Klein T E, |
CYP2D6 polymorphisms influence tamoxifen treatment outcomes in breast cancer patients: a meta-analysis. Cancer chemotherapy and pharmacology 2013 Aug 72 (2): 287-303. Zeng Zhiyu, Liu Yanqiong, Liu Zhiming, You Jianpeng, Chen Zhiping, Wang Jian, Peng Qiliu, Xie Li, Li Ruolin, Li Shan, Qin X |
Association between CYP2D6 genotypes and the clinical outcomes of adjuvant tamoxifen for breast cancer: a meta-analysis. Pharmacogenomics 2014 Jan 15 (1): 49-60. Jung Jin-A, Lim Hyeong-Se |
CYP2D6 genotype and tamoxifen response for breast cancer: a systematic review and meta-analysis. PloS one 2013 8 (10): e76648. Lum Danny W K, Perel Pablo, Hingorani Aroon D, Holmes Michael |
A Simulation Study to Compare the Treatment Effect of Tamoxifen by CYP2D6 Genotypes and Third-Generation Aromatase Inhibitors. Journal of clinical pharmacology 2017 Apr . Park Gwan Cheol, Jung Jin-A, Bae Kyun-Seop, Lim Hyeong-Se |
The effect of CYP2D6 *10 polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis. OncoTargets and therapy 2017 10 5429-5437. Lu Junjun, Li He, Guo Peng, Shen Rui, Luo Yingbin, Ge Qiao, Shi Wenfei, Li Yan, Zhu Weika |
Effects of CYP2D6*10 polymorphism on tamoxifen pharmacokinetics in patients with breast cancer in Asia: a meta-analysis. Cancer chemotherapy and pharmacology 2019 Jan 83 (1): 71-79. Bai Yu, Wu Hai-Wei, Zhang Yan-H |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: